Home > Financial Ratios > LAURUS LABS
COMMUNITY POLL
for LAURUS LABS
Please provide your vote to see the results

LAURUS LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 40.62-49.7011.16-8.68175.97

What is the latest Core EBITDA Growth ratio of LAURUS LABS ?

The latest Core EBITDA Growth ratio of LAURUS LABS is 40.62 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202540.62
Mar2024-49.70
Mar202311.16
Mar2022-8.68
Mar2021175.97

How is Core EBITDA Growth of LAURUS LABS Trending?

Years Core EBITDA Growth % Change
Mar2025 40.62
Positive
Mar2024 -49.7
Negative
Mar2023 11.16
Positive
Mar2022 -8.68
Negative
Mar2021 175.97 -

Other Financial Ratios of LAURUS LABS


Compare Core EBITDA Growth ratio of peers of LAURUS LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LAURUS LABS ₹75,289.1 Cr 1% 19.6% 126.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,349.0 Cr -3% -1.9% 7.5% Stock Analytics
DIVIS LABORATORIES ₹174,543.0 Cr -3.3% -0.7% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,884.0 Cr -3.8% 2.8% 36.4% Stock Analytics
CIPLA ₹111,077.0 Cr -3% 3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,388.0 Cr -4.3% -2% 2.5% Stock Analytics


LAURUS LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LAURUS LABS

1%

19.6%

126.5%

SENSEX

-2.2%

-3.3%

-8.8%


You may also like the below Video Courses